|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang C, Zhang F, Fan H, Peng L, Zhang R,
Liu S and Guo Z: Sequence polymorphisms of mitochondrial D-loop and
hepatocellular carcinoma outcome. Biochem Biophys Res Commun.
406:493–496. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Forner A, Llovet JM and Bruix J:
Hepatocellular carcinoma. Lancet. 379:1245–1255. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shindoh J, Hasegawa K, Inoue Y, Ishizawa
T, Nagata R, Aoki T, Sakamoto Y, Sugawara Y, Makuuchi M and Kokudo
N: Risk factors of post-operative recurrence and adequate surgical
approach to improve long-term outcomes of hepatocellular carcinoma.
HPB Oxf. 15:31–39. 2013. View Article : Google Scholar
|
|
6
|
Hu MC, Qiu WR, Wang YP, Hill D, Ring BD,
Scully S, Bolon B, DeRose M, Luethy R, Simonet WS, et al: FGF-18, a
novel member of the fibroblast growth factor family, stimulates
hepatic and intestinal proliferation. Mol Cell Biol. 18:6063–6074.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cinque L, Forrester A, Bartolomeo R,
Svelto M, Venditti R, Montefusco S, Polishchuk E, Nusco E, Rossi A,
Medina DL, et al: FGF signalling regulates bone growth through
autophagy. Nature. 528:272–275. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu Z, Lavine KJ, Hung IH and Ornitz DM:
FGF18 is required for early chondrocyte proliferation, hypertrophy
and vascular invasion of the growth plate. Dev Biol. 302:80–91.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hung IH, Schoenwolf GC, Lewandoski M and
Ornitz DM: A combined series of Fgf9 and Fgf18 mutant
alleles identifies unique and redundant roles in skeletal
development. Dev Biol. 411:72–84. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dahlberg LE, Aydemir A, Muurahainen N,
Gühring H, Edebo Fredberg H, Krarup-Jensen N, Ladel CH and Jurvelin
JS: A first-in-human, double-blind, randomised, placebo-controlled,
dose ascending study of intra-articular rhFGF18 (sprifermin) in
patients with advanced knee osteoarthritis. Clin Exp Rheumatol.
34:445–450. 2016.PubMed/NCBI
|
|
11
|
Itoh N, Nakayama Y and Konishi M: Roles of
FGFs as paracrine or endocrine signals in liver development,
health, and disease. Front Cell Dev Biol. 4:302016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Davidson D, Blanc A, Filion D, Wang H,
Plut P, Pfeffer G, Buschmann MD and Henderson JE: Fibroblast growth
factor (FGF) 18 signals through FGF receptor 3 to promote
chondrogenesis. J Biol Chem. 280:20509–20515. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Koneczny I, Schulenburg A, Hudec X,
Knöfler M, Holzmann K, Piazza G, Reynolds R, Valent P and Marian B:
Autocrine fibroblast growth factor 18 signaling mediates
Wnt-dependent stimulation of CD44-positive human colorectal adenoma
cells. Mol Carcinog. 54:789–799. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
El-Gendi S, Abdelzaher E, Mostafa MF and
Sheasha GA: FGF18 as a potential biomarker in serous and mucinous
ovarian tumors. Tumour Biol. 37:3173–3183. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wei W, Mok SC, Oliva E, Kim SH, Mohapatra
G and Birrer MJ: FGF18 as a prognostic and therapeutic biomarker in
ovarian cancer. J Clin Invest. 123:4435–4448. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sonvilla G, Allerstorfer S, Stättner S,
Karner J, Klimpfinger M, Fischer H, Grasl-Kraupp B, Holzmann K,
Berger W, Wrba F, et al: FGF18 in colorectal tumour cells:
Autocrine and paracrine effects. Carcinogenesis. 29:15–24. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Flannery CA, Fleming AG, Choe GH, Naqvi H,
Zhang M, Sharma A and Taylor HS: Endometrial cancer-associated
FGF18 expression is reduced by bazedoxifene in human endometrial
stromal cells in vitro and in murine endometrium. Endocrinology.
157:3699–3708. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Forner A: Hepatocellular carcinoma
surveillance with miRNAs. Lancet Oncol. 16:743–745. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hayes CN and Chayama K: MicroRNAs as
biomarkers for liver disease and hepatocellular carcinoma. Int J
Mol Sci. 17:2802016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shen S, Lin Y, Yuan X, Shen L, Chen J,
Chen L, Qin L and Shen B: Biomarker microRNAs for diagnosis,
prognosis and treatment of hepatocellular carcinoma: A functional
survey and comparison. Sci Rep. 6:383112016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee
DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, et al:
Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic
Acids Res. 33:e1792005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Soifer HS, Rossi JJ and Saetrom P:
MicroRNAs in disease and potential therapeutic applications. Mol
Ther. 15:2070–2079. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Baker M: RNA interference: MicroRNAs as
biomarkers. Nature. 464:12272010. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cui L, Zhang X, Ye G, Zheng T, Song H,
Deng H, Xiao B, Xia T, Yu X, Le Y, et al: Gastric juice MicroRNAs
as potential biomarkers for the screening of gastric cancer.
Cancer. 119:1618–1626. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li HC, Chen YF, Feng W, Cai H, Mei Y,
Jiang YM, Chen T, Xu K and Feng DX: Loss of the Opa interacting
protein 5 inhibits breast cancer proliferation through
miR-139-5p/NOTCH1 pathway. Gene. 603:1–8. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Krowiorz K, Ruschmann J, Lai C, Ngom M,
Maetzig T, Martins V, Scheffold A, Schneider E, Pochert N, Miller
C, et al: MiR-139-5p is a potent tumor suppressor in adult acute
myeloid leukemia. Blood Cancer J. 6:e5082016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yonemori M, Seki N, Yoshino H, Matsushita
R, Miyamoto K, Nakagawa M and Enokida H: Dual tumor-suppressors
miR-139-5p and miR-139-3p targeting matrix
metalloprotease 11 in bladder cancer. Cancer Sci.
107:1233–1242. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu H, Yin Y, Hu Y, Feng Y, Bian Z, Yao S,
Li M, You Q and Huang Z: miR-139-5p sensitizes colorectal cancer
cells to 5-fluorouracil by targeting NOTCH-1. Pathol Res Pract.
212:643–649. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang P, Xi J and Liu S: MiR-139-3p
induces cell apoptosis and inhibits metastasis of cervical cancer
by targeting NOB1. Biomed Pharmacother. 83:850–856. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sun C, Sang M, Li S, Sun X, Yang C, Xi Y,
Wang L, Zhang F, Bi Y, Fu Y, et al: Hsa-miR-139-5p inhibits
proliferation and causes apoptosis associated with down-regulation
of c-Met. Oncotarget. 6:39756–39792. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li Q, Liang X, Wang Y, Meng X, Xu Y, Cai
S, Wang Z, Liu J and Cai G: miR-139-5p inhibits the
epithelial-mesenchymal transition and enhances the chemotherapeutic
sensitivity of colorectal cancer cells by downregulating BCL2. Sci
Rep. 6:271572016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen H, Xu H, Meng YG, Zhang Y, Chen JY
and Wei XN: miR-139-5p regulates proliferation, apoptosis, and cell
cycle of uterine leiomyoma cells by targeting TPD52. Onco Targets
Ther. 9:6151–6160. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dai S, Wang X, Li X and Cao Y:
MicroRNA-139-5p acts as a tumor suppressor by targeting ELTD1 and
regulating cell cycle in glioblastoma multiforme. Biochem Biophys
Res Commun. 467:204–210. 2015. View Article : Google Scholar : PubMed/NCBI
|
